blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2680826

EP2680826 - VITAMIN D COMPOSITION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  29.06.2018
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  21.07.2017
FormerGrant of patent is intended
Status updated on  23.04.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL
published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
D3 Pharma Limited
Onega House
112 Main Road
Sidcup
Kent DA14 6NE / GB
[2014/02]
Inventor(s)01 / HUATAN, Hiep
D3 Pharma Limited
Onega House
112 Main Road
Sidcup Kent DA14 6NE / GB
 [2014/02]
Representative(s)Docherty, Robert Charles, et al
Symbiosis IP Limited
York Biotech Campus
Office 14FA05
Sand Hutton
York, YO41 1LZ / GB
[N/P]
Former [2017/34]Docherty, Robert Charles, et al
Symbiosis IP Limited
NAFIC
Office 14FA05
Sand Hutton
York, North Yorkshire YO41 1LZ / GB
Former [2014/02]Docherty, Robert Charles
Symbiosis IP Limited Apollo House Eboracum Way
Heworth Green, York YO31 7RE / GB
Application number, filing date12712144.027.02.2012
[2017/34]
WO2012GB50434
Priority number, dateGB2011000351902.03.2011         Original published format: GB 201103519
GB2011000839319.05.2011         Original published format: GB 201108393
[2014/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012117236
Date:07.09.2012
Language:EN
[2012/36]
Type: A1 Application with search report 
No.:EP2680826
Date:08.01.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 07.09.2012 takes the place of the publication of the European patent application.
[2014/02]
Type: B1 Patent specification 
No.:EP2680826
Date:23.08.2017
Language:EN
[2017/34]
Search report(s)International search report - published on:EP07.09.2012
ClassificationIPC:A61K9/48, A61K31/593, A61P3/02
[2014/02]
CPC:
A61K9/4858 (EP,GB); A61K31/593 (EP,GB); A61P19/10 (EP);
A61P3/02 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/13]
Former [2014/02]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VITAMIN D ZUSAMMENSETZUNG[2017/18]
English:VITAMIN D COMPOSITION[2014/02]
French:COMPOSITION DE VITAMINE D[2014/02]
Former [2014/02]VITAMIN-D-ZUSAMMENSETZUNG
Entry into regional phase09.09.2013National basic fee paid 
09.09.2013Designation fee(s) paid 
09.09.2013Examination fee paid 
Examination procedure09.09.2013Amendment by applicant (claims and/or description)
09.09.2013Examination requested  [2014/02]
23.06.2014Despatch of a communication from the examining division (Time limit: M06)
03.11.2014Reply to a communication from the examining division
11.03.2016Observations by third parties
16.06.2016Despatch of a communication from the examining division (Time limit: M04)
27.07.2016Reply to a communication from the examining division
24.04.2017Communication of intention to grant the patent
12.07.2017Fee for grant paid
12.07.2017Fee for publishing/printing paid
12.07.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.06.2014
Opposition(s)24.05.2018No opposition filed within time limit [2018/31]
Fees paidRenewal fee
10.01.2014Renewal fee patent year 03
08.01.2015Renewal fee patent year 04
21.12.2015Renewal fee patent year 05
23.01.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.02.2012
AL23.08.2017
AT23.08.2017
CY23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
MC23.08.2017
MK23.08.2017
PL23.08.2017
PT23.08.2017
RO23.08.2017
RS23.08.2017
SI23.08.2017
SK23.08.2017
SM23.08.2017
TR23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
LU27.02.2018
MT27.02.2018
CH28.02.2018
LI28.02.2018
[2020/34]
Former [2020/31]HU27.02.2012
AT23.08.2017
CY23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
MC23.08.2017
MK23.08.2017
PL23.08.2017
PT23.08.2017
RO23.08.2017
RS23.08.2017
SI23.08.2017
SK23.08.2017
SM23.08.2017
TR23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
LU27.02.2018
MT27.02.2018
CH28.02.2018
LI28.02.2018
Former [2020/27]HU27.02.2012
AT23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
MC23.08.2017
PL23.08.2017
PT23.08.2017
RO23.08.2017
RS23.08.2017
SI23.08.2017
SK23.08.2017
SM23.08.2017
TR23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
LU27.02.2018
MT27.02.2018
CH28.02.2018
LI28.02.2018
Former [2020/16]AT23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
MC23.08.2017
PL23.08.2017
RO23.08.2017
RS23.08.2017
SI23.08.2017
SK23.08.2017
SM23.08.2017
TR23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
LU27.02.2018
MT27.02.2018
CH28.02.2018
LI28.02.2018
Former [2020/08]AT23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
MC23.08.2017
PL23.08.2017
RO23.08.2017
RS23.08.2017
SI23.08.2017
SK23.08.2017
SM23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
LU27.02.2018
MT27.02.2018
CH28.02.2018
LI28.02.2018
Former [2018/52]AT23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
MC23.08.2017
PL23.08.2017
RO23.08.2017
RS23.08.2017
SI23.08.2017
SK23.08.2017
SM23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
LU27.02.2018
CH28.02.2018
LI28.02.2018
Former [2018/44]AT23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
MC23.08.2017
PL23.08.2017
RO23.08.2017
RS23.08.2017
SI23.08.2017
SK23.08.2017
SM23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
Former [2018/39]AT23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
PL23.08.2017
RO23.08.2017
RS23.08.2017
SI23.08.2017
SK23.08.2017
SM23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
Former [2018/24]AT23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
PL23.08.2017
RO23.08.2017
RS23.08.2017
SK23.08.2017
SM23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
Former [2018/23]AT23.08.2017
CZ23.08.2017
EE23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
PL23.08.2017
RO23.08.2017
RS23.08.2017
SK23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
Former [2018/21]AT23.08.2017
CZ23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
PL23.08.2017
RS23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
Former [2018/12]AT23.08.2017
HR23.08.2017
LT23.08.2017
LV23.08.2017
PL23.08.2017
RS23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
Former [2018/11]AT23.08.2017
HR23.08.2017
LT23.08.2017
PL23.08.2017
RS23.08.2017
BG23.11.2017
NO23.11.2017
GR24.11.2017
IS23.12.2017
Former [2018/10]AT23.08.2017
HR23.08.2017
LT23.08.2017
RS23.08.2017
NO23.11.2017
Former [2018/07]LT23.08.2017
NO23.11.2017
Cited inInternational search[XI]WO03059358  (ROCHE VITAMINS AG [CH], et al);
 [Y]WO2006116204  (NOVACEA INC [US], et al);
 [Y]WO2008134512  (CYTOCHROMA INC [CA], et al);
 [XI]WO2010111397  (ADDS PHARMACEUTICALS LLC [US], et al);
by applicantUS2003191093
 WO2009009134
 US2009196862
 WO2009098295
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.